pharmaphorum Podcast
Medical
pharmaphorum is one of the leading global channels for insight into the pharma and healthcare industry – and is essentially a group of passionate people who like asking excellent questions. Our podcasts offer a chance to pose some of these questions to the keenest minds in our industry to look at the big issues and opportunities facing pharma, biotech and healthcare today. With interviews and contributions from a host of industry experts and insiders, the pharmaphorum podcast is a must-listen for those who want insight into the future of health and medicine.
Location:
United States
Description:
pharmaphorum is one of the leading global channels for insight into the pharma and healthcare industry – and is essentially a group of passionate people who like asking excellent questions. Our podcasts offer a chance to pose some of these questions to the keenest minds in our industry to look at the big issues and opportunities facing pharma, biotech and healthcare today. With interviews and contributions from a host of industry experts and insiders, the pharmaphorum podcast is a must-listen for those who want insight into the future of health and medicine.
Language:
English
Website:
https://pharmaphorum.podbean.com
Episodes
Clinical trials: their design, location, and, potentially, their simulation
5/8/2024
Clinical trials, their design and location, and these days their simulation, are the focus of today’s podcast with Dr Gen Li, founder and president of Phesi.
Duration:00:17:09
Pace, acceleration, and precision are the name of the game
5/2/2024
Security and privacy within biotech are critical points of consideration and discussion as the industry continues to innovate at speed, and it is such aspects that are central to today’s podcast with Zach Powers, chief information security officer at Benchling, the R&D cloud platform for the biotech industry.
Duration:00:20:34
Technology working as the puzzle piece to bring better outcomes to patients
4/30/2024
While at Reuters Pharma Europe in Barcelona the other week, pharmaphorum web editor Nicole Raleigh spoke with Florian Schnappauf, VP of enterprise commercial strategy at Veeva Europe, about commercial strategy and digitalising commercial operations.
Duration:00:18:28
Is precision psychiatry possible?
4/25/2024
On today’s podcast, host Jonah Comstock is joined by Dr Amit Etkin, founder and CEO of Alto Neuroscience, a recently IPO'd biotech that wants to bring precision medicine to psychiatry. But what do we mean when we talk about precision, especially in a discipline like mental health that has historically involved a lot of objectivity?
Duration:00:35:38
Encouraging early engagement to revitalise Europe’s pharmaceutical landscape
4/23/2024
In an on-site interview at Reuters Pharma Europe in Barcelona, this week’s podcast saw Tommy Bramley, SVP of market access and healthcare consulting at Cencora, discuss revitalising Europe’s pharmaceutical landscape and leveraging legislation for health and competitiveness.
Duration:00:19:31
Predictions for AI in mental health in the coming year
4/18/2024
In a new episode of the pharmaphorum podcast, web editor Nicole Raleigh welcomes Dr Carl Marci, chief psychiatrist and managing director of mental health and neuroscience at OM1 to discuss predictions for AI in mental health in the coming year, as well as what might truly make a difference in the field and lessen the mental health crisis.
Duration:00:22:35
Fixing clinical trial data management
4/11/2024
It’s 2024 and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another. How did we get here? And how do we get past it? On today’s pharmaphorum podcast, host Jonah Comstock speaks with Iddo Peleg, CEO of Yonalink, about these very questions.
Duration:00:26:34
Harnessing the velocity of biopharmaceutical advances
4/9/2024
On today's episode of the podcast CEO and co-founder of 908 Devices Kevin Knopp joins as guest, discussing how such acceleration is by virtue of technological advancements, including the buzzword artificial intelligence (AI) and machine learning when it comes to bioprocessing.
Duration:00:18:10
Conference report: Reuters Pharma USA
4/4/2024
Last week, pharmaphorum Editor in Chief Jonah Comstock traveled to Philadelphia for Reuters Pharma USA. On today’s podcast, he chats with guest host and Deep Dive Editor Eloise McLellan about his biggest takeaways from the two-day event.
Duration:00:38:02
The future of AI: Machine learning working together with scientific expertise
4/2/2024
In a new episode of the pharmaphorum podcast recorded live on site at WIRED Health in London in March, web editor Nicole Raleigh spoke with Elise de Reus, co-founder of Cradle, the generative AI platform that helps scientists to design and program proteins.
Duration:00:10:28
Understanding the politics of drug pricing in the United States
3/28/2024
Everyone says they want more affordable drugs for patients that need them, but people disagree quite a bit on who's to blame for the current status quo of sky-high prescription prices – not to mention how they might be corrected.
To help unpack some of those trends and conflicting perspectives, Brandon Newman, CEO of healthcare analytics firm Xevant, joins host Jonah Comstock on today’s episode of the pharmaphorum podcast.
Duration:00:35:53
Female leadership and lessening disease burden
3/26/2024
As Women’s History Month comes to its final week, today’s podcast sees web editor Nicole Raleigh in conversation with Debra Weiss, COO of the Bill & Melinda Gates Medical Research Institute (Gates MRI), discussing her role as a female leader in the leader and the non-profit organisation’s work in developing novel biomedical interventions and lessening the burden of disease in LMICs.
Duration:00:14:59
The unique clinical trial challenges faced by digital therapeutics
3/21/2024
On today’s podcast, host Jonah Comstock is joined by Meri Beckwith, cofounder of Lindus Health, a next-gen CRO that includes digital therapeutics among its specialties. They talk a little bit about often unseen difficulties of validating a digital therapeutic through a clinical trial.
Duration:00:27:56
The unmentionables: Challenging inequalities in women’s health
3/19/2024
As Women’s History Month continues, pharmaphorum web editor Nicole Raleigh welcomed a group of expert individuals onto the podcast to discuss not just the inequalities in women’s health, but female leaders within life sciences, too.
The guests included: Trine Bartholdy, chief innovation executive at the BioInnovation Institute (BII) in Denmark; Karin Lykke-Hartmann, CEO and founder of Notify Therapeutics; Julia Sand Skovsted, co-founder and CCO of Oasicare; and Maj Hedtjärn, Entrepreneur in Residence for the CurE-Me project.
Duration:00:47:42
The next chapter for AI protein structure prediction
3/14/2024
On today’s pharmaphorum podcast, Glen Gowers, cofounder of Basecamp Research, gets into the company’s recent pre-print paper and how it improves upon AlphaFold 2, the current gold standard for protein folding prediction.
Duration:00:28:01
Avoiding the data swamp: The transformative power of AI
3/12/2024
In the latest episode of the pharmaphorum podcast, host Nicole Raleigh speaks (virtually) with Nathan Clark, founder and CEO of Ganymede, a modern data platform and Cloud infrastructure for science, to discuss the evolving role of the Cloud in biopharma and some rather revolutionary tools in AI drug discovery.
Duration:00:17:56
How natural language processing can make a difference in pharma
3/7/2024
On today’s podcast, host Jonah Comstock welcomes Jane Reed, director of life sciences at IQVIA NLP, the new name for recent IQVIA acquisition Linguamatics. Jane talks through some of these different technologies and use cases and describes how natural language processing has exciting potential in translating real-world conversations on social media into pharmaceutical adverse event reports.
Duration:00:22:32
Transitioning from traditional surgical methods to the innovative use of stem cells.
3/5/2024
In today’s podcast, host Nicole Raleigh welcomes Dr Jeffrey Gross, founder of ReCELLebrate, neurological surgeon, and expert in the field of regenerative medicine, to discuss this development. Their conversation delves into the recent appetite for the use of stem cells for longevity and explores the ‘health span’ notion that is being ever more frequently spoken of.
Duration:00:18:35
The 2024 biopharma M&A landscape: An overview
2/29/2024
It's been a couple of months since pharma’s annual JP Morgan Chase Healthcare Conference, where the mood around pharma M&A this year was optimistic, albeit with a few caveats. On today’s podcast, host Jonah Comstock is joined by Cody Powers, principal of portfolio and business development at ZS Associates, to discuss those trends and predictions and how they’re shaking out so far.
Duration:00:31:28
Accelerating the process, transforming therapies and advancing precision medicine
2/27/2024
In this episode of the pharmaphorum podcast, host Nicole Raleigh speaks with Dr Mohit Jain, founder and CEO of Sapient, a biomarker discovery lab providing expert services and actionable insights to better personalise disease prediction, diagnostics, and therapies.
Duration:00:22:00